HAYLEY LUNDEEN: Open Payments
NPI 1316477342 · OREM, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,680 in 64 payments from 19 companies in 2025. Trend: 2023 $1,473 · 2024 $1,128 · 2025 $3,680
Food & beverage: $2,128Travel & lodging: $1,552
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 10 | $2,596 |
| PFIZER INC. | 14 | $218 |
| Amgen Inc. | 9 | $182 |
| Novartis Pharmaceuticals Corporation | 6 | $112 |
| E.R. Squibb & Sons, L.L.C. | 4 | $84 |
| Actelion Pharmaceuticals US, Inc. | 4 | $78 |
| BridgeBio Pharma, Inc. | 3 | $75 |
| Abbott Laboratories | 2 | $64 |
| HEARTFLOW, INC. | 2 | $58 |
| United Therapeutics Corporation | 1 | $33 |
Products named: FARAPULSE, REPATHA, ELIQUIS, LEQVIO, CAMZYOS, UPTRAVI, Attruby, VYNDAQEL.
Industry payments across UT — which companies pay providers there.
